LAURA RYSSO: Open Payments
NPI 1093156010 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 53 payments from 19 companies in 2025. Trend: 2023 $1,134 · 2024 $1,339 · 2025 $1,098
Food & beverage: $1,098
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $202 |
| AstraZeneca Pharmaceuticals LP | 7 | $179 |
| Novo Nordisk Inc | 6 | $107 |
| Astellas Pharma US Inc | 3 | $77 |
| PFIZER INC. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Madrigal Pharmaceuticals | 2 | $45 |
| Lilly USA, LLC | 2 | $37 |
Products named: VRAYLAR, AIRSUPRA, Veozah, NURTEC ODT, JARDIANCE, Ozempic, FARXIGA, Kerendia.
Industry payments across MI — which companies pay providers there.
